Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New digital cognitive test for Alzheimer’s disease

Written by | 30 Sep 2025

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer’s disease. The diagnostic is intended for use in primary care. Using a tablet… read more.

GLP-1 RAs reduce dementia risks more than metformin

Written by | 26 Jul 2025

Researchers report that treatment of type 2 diabetes with glucagon- like peptide- 1 receptor agonists (GLP- 1 RAs) more effectively reduces the subsequent risk of dementia than treatment… read more.

Elucidation of part of the mechanism by which lecanemab slows the progression of Alzheimer’s disease – Eisai

Written by | 24 Jan 2025

A collaborative research group led by Professor Kenjiro Ono of the Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, and Eisai Co., Ltd., used a newly developed… read more.

FDA accepts filing of Leqembi (lecanemab-irmb) supplemental biologics license application for IV maintenance dosing for the treatment of early Alzheimer’s disease – Eisai + Biogen

Written by | 26 Jun 2024

Eisai Co. Ltd. and Biogen Inc. announced that that the FDA has accepted Eisai’s Supplemental Biologics License Application (sBLA) for monthly lecanemab-irmb (U.S. brand name: Leqembi) intravenous (IV)… read more.

New blood test gives very high accuracy to screen for Alzheimer’s disease

Written by | 2 Sep 2023

A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude… read more.

Alzheimer’s disease: is diet key to dementia?

Written by | 7 Feb 2023

A new decade-long study of older adults in China has found that a healthy lifestyle, in particular a good diet, is associated with slower memory decline. Researchers say… read more.

Social isolation linked to neurodegeneration

Written by | 6 Feb 2023

Social lifestyle determinants, including social isolation, are associated with neurodegeneration risk factors, according to a new study published PLOS ONE by scientists at McGill University, Canada. Alzheimer’s disease (AD) is… read more.

Six minutes of high-intensity exercise could delay the onset of Alzheimer’s disease

Written by | 18 Jan 2023

Six minutes of high-intensity exercise could extend the lifespan of a healthy brain and delay the onset of neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease. New… read more.

Single brain scan can diagnose Alzheimer’s disease

Written by | 21 Jun 2022

The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated with Alzheimer’s. The advantage of the technique is… read more.

Psychiatric symptoms in Alzheimers disease

Written by | 20 Apr 2022

In addition to memory problems and other cognitive symptoms, most people with Alzheimer’s disease also suffer from mental health issues. It has long been unclear whether these occur… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.